Jeffrey L. Purvin

Jeffrey L. Purvin is a declared insider of Response Biomedical Corp, with filings sourced from SEDI. We count 8 filings; the first trade dates from 15 August 2012 and the latest from 4 December 2013.

Purchases make up the whole of the open-market record (8 purchases, €35k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2013 to date brings 5 purchases and no sales.

Half of the purchases are above €2,890 and half below.

Most recently, on 5 December 2013, the filings show an open-market purchase worth €764 in Response Biomedical Corp. Filings reach the SEDI feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.